Cited by 664Metabolism and Genetic DisordersLysosomal Storage Disorders ResearchHereditary Neurological Disorders

The DOI matches its Crossref record; 98 of the 99 references it cites were found in a registry or an index.

X-linked adrenoleukodystrophy

Moser, Hugo W, Mahmood, Asif, Raymond, Gerald V·2007·Nature Clinical Practice Neurology

Open this paper in CoChat — free account

Abstract

X-linked adrenoleukodystrophy (X-ALD) is caused by a defect in the gene ABCD1, which maps to Xq28 and codes for a peroxisomal membrane protein that is a member of the ATP-binding cassette transporter superfamily. X-ALD is panethnic and affects approximately 1:20,000 males. Phenotypes include the rapidly progressive childhood, adolescent, and adult cerebral forms; adrenomyeloneuropathy, which presents as slowly progressive paraparesis in adults; and Addison disease without neurologic manifestations. These phenotypes are frequently misdiagnosed, respectively, as attention-deficit hyperactivity disorder (ADHD), multiple sclerosis, or idiopathic Addison disease. Approximately 50% of female carriers develop a spastic paraparesis secondary to myelopathic changes similar to adrenomyeloneuropathy. Assays of very long chain fatty acids in plasma, cultured chorion villus cells and amniocytes, and mutation analysis permit presymptomatic and prenatal diagnosis, as well as carrier identification. The timely use of these assays is essential for genetic counseling and therapy. Early diagnosis and treatment can prevent overt Addison disease, and significantly reduce the frequency of the severe childhood cerebral phenotype. A promising new method for mass newborn screening has been developed, the implementation of which will have a profound effect on the diagnosis and therapy of X-ALD.

Integrity signals

Registry

Crossref · 10.1038/ncpneuro0421

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Case 39-2000
Rochester, C. L., & Kradin, R. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432509 · Cited by 3,875
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citation
Adrenoleukodystrophy: A Clinical and Pathological Study of 17 Cases
Schaumburg, H. H. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510033001 · Cited by 475
Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brain
Moskvitina, T. A., Kamyshanskaya, N. S., Kaverina, L. P., & Gorkin, V. Z. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04462.x · Cited by 440
Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999
Peters, C., Charnas, L. R., Tan, Y., Ziegler, R. S., Shapiro, E. G., DeFor, T., Grewal, S. S., Orchard, P. J., Abel, S. L., Goldman, A. I., et al. (2004) · Blood · doi:10.1182/blood-2003-10-3402 · Cited by 374
Self-citation
Reversal of Early Neurologic and Neuroradiologic Manifestations of X-Linked Adrenoleukodystrophy by Bone Marrow Transplantation
Aubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G., Naud-Saudreau, C., Rolland, M.-O., Debré, M., Chaussain, J.-L., Griscelli, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222607 · Cited by 366
Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.
Singh, I., Moser, A. E., Goldfischer, S. L., & Moser, H. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.4203 · Cited by 348
Self-citation

Show all 99 references

Research works printed but not linked: 2

Koehler W and Sokolowski P (2005) Clinical phenotypes, diagnosis and treatment of adulthood X-linked adrenoleukodystrophy. In Understanding and Treating Adrenoleukodystrophy. Present State and Future Perspectives, 28–60 (Eds Berger J et al.) SPS Verlagsgessellschaft: Heilbronn
Mahmood A et al. (2005) Evaluating survival in nontransplanted boys with the cerebral phenotype of X-linked adrenoleukodystrophy [abstract]. Ann Neurol 58 (Suppl 9): 52a

Sorted by citations

Items 101–200 of 664

The molecular genetics of male infertility
Meschede, D. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.5.419 · Cited by 82
Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy
Morató, L., Galino, J., Ruíz, M., Calingasan, N. Y., Starkov, A. A., Dumont, M., Naudí, A., Martínez, J. J., Aubourg, P. R., Portero‐Otín, M., et al. (2013) · Brain · doi:10.1093/brain/awt143 · Cited by 82
ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease
Kawaguchi, K., & Morita, M. (2016) · BioMed Research International · doi:10.1155/2016/6786245 · Cited by 81
Absence of correlation between oxysterol accumulation in lipid raft microdomains, calcium increase, and apoptosis induction on 158N murine oligodendrocytes
Ragot, K., Mackrill, J. J., Zarrouk, A., Nury, T., Aires, V., Jacquin, A., Athias, A., de Barros, J.-P. P., Véjux, A., Riedinger, J., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.028 · Cited by 80
Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: A retrospective study
van Geel, B. M., Poll‐The, B. T., Verrips, A., Boelens, J., Kemp, S., & Engelen, M. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9797-1 · Cited by 78
Peroxisomal Multifunctional Protein 2 Is Essential for Lipid Homeostasis in Sertoli Cells and Male Fertility in Mice
Huyghe, S., Schmalbruch, H., Gendt, K. D., Verhoeven, G., Guillou, F., Veldhoven, P. P. V., & Baes, M. I. (2006) · Endocrinology · doi:10.1210/en.2005-1571 · Cited by 76
Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred
Baba, Y., Ghetti, B., Baker, M. C., Uitti, R. J., Hutton, M. L., Yamaguchi, K., Bird, T., Lin, W., DeLucia, M. W., Dickson, D. W., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0046-z · Cited by 106
Peroxisomal disorders
Aubourg, P. R., & Wanders, R. J. A. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00028-9 · Cited by 75
Mitochondrial dysfunction in central nervous system white matter disorders
Morató, L., Bertini, E., Verrigni, D., Ardissone, A., Ruíz, M., Ferrer, I., Uziel, G., & Pujol, A. (2014) · Glia · doi:10.1002/glia.22670 · Cited by 77
Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis
Titus, H. E., Chen, Y., Podojil, J. R., Robinson, A. P., Balabanov, R. D., Popko, B., & Miller, S. D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.599717 · Cited by 88
Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation
Maier, E. M., Kammerer, S., Muntau, A. C., Wichers, M., Braun, A., & Roscher, A. A. (2002) · Annals of Neurology · doi:10.1002/ana.10376 · Cited by 72
Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy
Huffnagel, I. C., van de Beek, M.-C., Showers, A. L., Orsini, J. J., Klouwer, F. C. C., Dijkstra, I. M. E., Schielen, P. C., van Lenthe, H., Wanders, R. J. A., Vaz, F. M., et al. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.10.012 · Cited by 71
X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes
Weber, F. D., Wiesinger, C., Forss-Petter, S., Regelsberger, G., Einwich, A., Weber, W. H. A., Kohler, W., Stockinger, H., & Berger, J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt645 · Cited by 63
A Thyroid Hormone–Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy
Hartley, M. D., Kirkemo, L. L., Banerji, T., & Scanlan, T. S. (2017) · Endocrinology · doi:10.1210/en.2016-1842 · Cited by 71
Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator
Gondcaille, C., Depreter, M., Fourcade, S., Lecca, M. R., Leclercq, S., Martin, P. G. P., Pineau, T., Cadepond, F., El‐Etr, M., Bertrand, N., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501036 · Cited by 70
Thyroid Hormone Signaling in Oligodendrocytes: from Extracellular Transport to Intracellular Signal
Lee, J. Y., & Petratos, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0013-1 · Cited by 71
Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene
Sevin, C., Ferdinandusse, S., Waterham, H. R., Wanders, R. J., & Aubourg, P. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-8 · Cited by 66
Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
Barendsen, R. W., Dijkstra, I. M. E., Visser, W. F., Alders, M., Bliek, J., Boelen, A., Bouva, M. J., van der Crabben, S. N., Elsinghorst, E., van Gorp, A. G. M., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00499 · Cited by 65
Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy
Fatemi, A., Smith, S. A., Dubey, P., Zackowski, K. M., Bastian, A. J., van Zijl, P. C., Moser, H. W., Raymond, G. V., & Golay, X. (2005) · Neurology · doi:10.1212/01.wnl.0000164458.02141.06 · Cited by 64
Self-citation
Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated
Jangouk, P., Zackowski, K. M., Naidu, S., & Raymond, G. V. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.001 · Cited by 63
Self-citation
Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy
Launay, N., Ruíz, M., Grau, L., Ortega, F. J., Ilieva, E. V., Martínez, J. J., Galea, E., Ferrer, I., Knecht, E., Pujol, A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1655-9 · Cited by 63
Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's Oil)
Rasmussen, M., Moser, A. B., Borel, J. S., Khangoora, S., & Moser, H. W. (1994) · Neurochemical Research · doi:10.1007/bf00968719 · Cited by 62
Self-citation
Neurocognitive trajectory of boys who received a hematopoietic stem cell transplant at an early stage of childhood cerebral adrenoleukodystrophy
Pierpont, E. I., Eisengart, J. B., Shanley, R., Nascene, D., Raymond, G. V., Shapiro, E. G., Ziegler, R. S., Orchard, P. J., & Miller, W. P. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0013 · Cited by 62
Self-citation
Human Liver-Specific Very-Long-Chain Acyl-Coenzyme A Synthetase: cDNA Cloning and Characterization of a Second Enzymatically Active Protein
Steinberg, S. J., Wang, S. J., McGuinness, M. C., & Watkins, P. A. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2883 · Cited by 62
Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy
Rattay, T. W., Rautenberg, M., Söhn, A. S., Hengel, H., Traschütz, A., Röben, B., Hayer, S. N., Schüle, R., Wiethoff, S., Zeltner, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71248-8 · Cited by 61
Leukoencephalopathies associated with inborn errors of metabolism in adults
Sedel, F., Tourbah, A., Fontaine, B., Lubetzki, C., Baumann, N., Saudubray, J., & Lyon‐Caen, O. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0778-0 · Cited by 61
Epidemiology of X-linked adrenoleukodystrophy in Japan
Takemoto, Y., Suzuki, Y., Tamakoshi, A., Onodera, O., Tsuji, S., Hashimoto, T., Shimozawa, N., Orii, T., & Kondo, N. (2002) · Journal of Human Genetics · doi:10.1007/s100380200090 · Cited by 61
Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature
Çakmakçı, H., Pekçevik, Y., Yiş, U., Ünalp, A., & Kurul, S. H. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.05.048 · Cited by 60
Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo
Guimarães, C. P., Domingues, P. M., Aubourg, P. R., Fouquet, F., Pujol, A., Jiménez‐Sánchez, G., Sá-Miranda, C., & Azevedo, J. E. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.04.001 · Cited by 60
Magnetic Resonance Imaging Detection of Lesion Progression in Adult Patients With X-linked Adrenoleukodystrophy
Eichler, F., Mahmood, A., Loes, D. J., Bezman, L., Lin, D., Moser, H. W., & Raymond, G. V. (2007) · Archives of Neurology · doi:10.1001/archneur.64.5.659 · Cited by 60
Self-citation
Human very long-chain acyl-CoA synthetase and two human homologs: initial characterization and relationship to fatty acid transport protein
Watkins, P. A., Pevsner, J., & Steinberg, S. J. (1999) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80007-6 · Cited by 60
Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy
Weinhofer, I. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2701 · Cited by 59
Therapy of X-linked adrenoleukodystrophy
Moser, H. W. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.004 · Cited by 59
Self-citation
ω-Oxidation of Very Long-chain Fatty Acids in Human Liver Microsomes
Sanders, R., Ofman, R., Durán, M., Kemp, S., & Wanders, R. J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513481200 · Cited by 59
Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients
Weller, S., Rosewich, H., & Gärtner, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0856-3 · Cited by 58
Newborn screening for X-linked adrenoleukodystrophy: Further evidence high throughput screening is feasible
Theda, C., Gibbons, K., DeFor, T. E., Donohue, P. K., Golden, W. C., Kline, A. D., Gulamali-Majid, F., Panny, S. R., Hubbard, W. C., Jones, R. O., et al. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.10.019 · Cited by 56
Self-citation
Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy
Fourcade, S., López-Erauskin, J., Ruiz, M., Ferrer, I., & Pujol, A. (2014) · Biochimie · doi:10.1016/j.biochi.2013.09.012 · Cited by 55
Postnatal diagnosis of peroxisomal disorders: A biochemical approach
Wanders, R. J. A., Schutgens, R. B. H., Barth, P. G., Tager, J. M., & van den BOSCH, H. (1993) · Biochimie · doi:10.1016/0300-9084(93)90087-9 · Cited by 55
Metabolic injury to axons and myelin
Tsutsui, S., & Stys, P. K. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.04.016 · Cited by 54
MR Imaging Characteristics and Neuropathology of the Spinal Cord in Adult-Onset Autosomal Dominant Leukodystrophy with Autonomic Symptoms
Sundblom, J., Melberg, A., Kalimo, H., Smits, A., & Raininko, R. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1354 · Cited by 54
Molecular and clinical aspects of peroxisomal diseases
Shimozawa, N. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0516-z · Cited by 53
Modeling and rescue of defective blood–brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients
Lee, C. A. A., Seo, H. S., Armien, A. G., Bates, F. S., Tolar, J., & Azarin, S. M. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0094-5 · Cited by 52
Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: A diagnostic approach
Sedel, F., Fontaine, B., Saudubray, J., & Lyon‐Caen, O. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0745-1 · Cited by 51
Characterization of the human ω‐oxidation pathway for ω‐hydroxy‐very‐long‐chain fatty acids
Sanders, R., Ofman, R., Dacremont, G., Wanders, R. J. A., & Kemp, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-099150 · Cited by 51
Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy
Launay, N., Aguado, C., Fourcade, S., Ruíz, M., Grau, L., Riera, J., Guilera, C., Girós, M., Ferrer, I., Knecht, E., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1378-8 · Cited by 55
Evaluation of pharmacological induction of fatty acid β-oxidation in X-linked Adrenoleukodystrophy
McGuinness, M. C., Zhang, H.-P., & Smith, K. D. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3239 · Cited by 51
X‐linked adrenoleukodystrophy: Biochemical diagnosis and enzyme defect
Wanders, R. J. A., van Roermund, C. W. T., Lageweg, W., Jakobs, B. S., Schutgens, R. B. H., Nijenhuis, A. A., & Tager, J. M. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799620 · Cited by 51
Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation
Kleinfeld, K., Mobley, B. C., Hedera, P., Wegner, A. M., Sriram, S., & Pawate, S. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6680-6 · Cited by 50
Endocrine Dysfunction in X-Linked Adrenoleukodystrophy
Burtman, E., & Regelmann, M. O. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.003 · Cited by 52
Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up
Matteson, J., Sciortino, S., Feuchtbaum, L., Bishop, T., Olney, R. S., & Tang, H. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7020022 · Cited by 50
DAX1 and its network partners: exploring complexity in development
Clipsham, R. C., & McCabe, E. R. B. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.023 · Cited by 54
Human Genome and Diseases:¶Cellular and molecular aspects of Zellweger syndrome and other peroxisome biogenesis disorders
Brosius, U., & Gärtner, J. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8486-7 · Cited by 50
Ethics of genetic counseling—basic concepts and relevance to Islamic communities
El-Hazmi, M. A. F. (2004) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2004.84 · Cited by 49
Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy
Khan, M., Singh, J., Gilg, A. G., Uto, T., & Singh, I. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002329 · Cited by 49
Therapy of X-linked adrenoleukodystrophy
Semmler, A., Köhler, W., Jung, H. H., Weller, M., & Linnebank, M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.9.1367 · Cited by 49
Bezafibrate lowers very long‐chain fatty acids in X‐linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
Engelen, M., Schackmann, M. J. A., Ofman, R., Sanders, R., Dijkstra, I. M. E., Houten, S. M., Fourcade, S., Pujol, A., Poll‐The, B. T., Wanders, R. J. A., et al. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9471-4 · Cited by 49
The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage
Lu, J., Barron‐Casella, E. A., Brose, R. D., Heinzer, A. K., Moser, A. B., Bentley, K. L. D. M., Wand, G. S., McGuinness, M. C., Pei, Z., Watkins, P. A., et al. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700512 · Cited by 48
C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man
van de Beek, M.-C., Dijkstra, I. M. E., van Lenthe, H., Ofman, R., Goldhaber-Pasillas, D., Schauer, N., Schackmann, M., Engelen-Lee, J.-Y., Vaz, F. M., Kulik, W., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154597 · Cited by 48
ABCD1 dysfunction alters white matter microvascular perfusion
Lauer, A., Da, X., Hansen, M. B., Boulouis, G., Ou, Y., Cai, X., Liberato Celso Pedrotti, A., Kalpathy-Cramer, J., Caruso, P., Hayden, D. L., et al. (2017) · Brain · doi:10.1093/brain/awx262 · Cited by 48
Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy
Baumann, M., Korenke, C., Weddige-Diedrichs, A., Wilichowski, E., Hunneman, D., Wilken, B., Brockmann, K., Klingebiel, T., Niethammer, D., Kühl, J., et al. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1097-3 · Cited by 47
Oxidative stress regulates the ubiquitin–proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy
Launay, N., Ruíz, M., Fourcade, S., Schlüter, A., Guilera, C., Ferrer, I., Knecht, E., & Pujol, A. (2013) · Brain · doi:10.1093/brain/aws370 · Cited by 50
Immune Response in Leukodystrophies
Eichler, F., & van Haren, K. P. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.06.011 · Cited by 49
Role of peroxisomes in human lipid metabolism and its importance for neurological development
Wanders, R. J. A., & Poll-The, B. T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2015.06.018 · Cited by 46
Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy
van de Beek, M.-C., Ofman, R., Dijkstra, I. M. E., Wijburg, F. A., Engelen, M., Wanders, R. J. A., & Kemp, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.003 · Cited by 48
Glutathione imbalance in patients with X-linked adrenoleukodystrophy
Petrillo, S., Piemonte, F., Pastore, A., Tozzi, G., Aiello, C., Pujol, A., Cappa, M., & Bertini, E. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.05.009 · Cited by 46
Generalised and conditional inactivation of Pex genes in mice
Baes, M. I., & Veldhoven, P. P. V. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.018 · Cited by 45
Peroxisomal Multifunctional Protein-2 Deficiency Causes Motor Deficits and Glial Lesions in the Adult Central Nervous System
Huyghe, S., Schmalbruch, H., Hulshagen, L., Veldhoven, P. P. V., Baes, M. I., & Hartmann, D. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.041220 · Cited by 46
Dietary Management of X-Linked Adrenoleukodystrophy
Moser, H. W., & Borel, J. S. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.002115 · Cited by 46
Self-citation
Peroxisomes, Lipid Metabolism, and Human Disease
Wanders, R. J. A. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:32:1-3:89 · Cited by 45
Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X‐linked adrenoleukodystrophy
Deon, M., Sitta, Â., Barschak, A. G., Coelho, D. M., Pigatto, M. C., Schmitt, G. O., Jardim, L. B., Giugliani, R., Wajner, M., & Vargas, C. R. (2007) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2007.08.008 · Cited by 43
Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia
Saputra, L., & Kumar, K. R. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01099-x · Cited by 43
Leukodystrophies
Perlman, S. J., & Mar, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_13 · Cited by 43
Oxidative Imbalance in Nonstimulated X-Adrenoleukodystrophy-Derived Lymphoblasts
Uto, T., Contreras, M. A., Gilg, A. G., & Singh, I. (2008) · Developmental Neuroscience · doi:10.1159/000191212 · Cited by 43
X‐linked adrenoleukodystrophy in Spain. Identification of 26 novel mutations in the ABCD1 gene in 80 patients. Improvement of genetic counseling in 162 relative females
Coll, M., Palau, N., Camps, C., Ruíz, M., Pàmpols, T., & Girós, M. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00423.x · Cited by 42
Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
Chiesa, R., Boelens, J. J., Duncan, C., Kühl, J., Sevin, C., Kapoor, N., Prasad, V. K., Lindemans, C. A., Jones, S. A., Amartino, H. M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005294 · Cited by 41
Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis
Schackmann, M. J. A., Ofman, R., Dijkstra, I. M. E., Wanders, R. J. A., & Kemp, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.005 · Cited by 41
Dysfunction of peroxisomes in twitcher mice brain: A possible mechanism of psychosine-induced disease
Haq, E., Contreras, M. A., Giri, S., Singh, I., & Singh, A. K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.131 · Cited by 41
Thyroid Hormone Induction of the Adrenoleukodystrophy-Related Gene (ABCD2)
Fourcade, S., Savary, S., Gondcaille, C., Berger, J., Netik, A., Cadepond, F., El‐Etr, M., Molzer, B., & Bugaut, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1296 · Cited by 41
X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype
Maier, E. M., Mayerhofer, P. U., Asheuer, M., Köhler, W., Rothe, M., Muntau, A. C., Roscher, A. A., Holzinger, A., Aubourg, P., & Berger, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.092 · Cited by 34
The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy
Rodríguez-Pascau, L., Vilalta, A., Cerrada, M., Traver, E., Forss-Petter, S., Weinhofer, I., Bauer, J., Kemp, S., Pina, G., Pascual, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc0555 · Cited by 40
α‐Synuclein abnormalities in mouse models of peroxisome biogenesis disorders
Yakunin, E., Moser, A. B., Loeb, V., Saada, A., Faust, P. L., Crane, D. I., Baes, M. I., & Sharon, R. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22246 · Cited by 39
Gene therapy for metabolic diseases
Chandler, R. J., & Venditti, C. P. (2016) · Translational Science of Rare Diseases · doi:10.3233/trd-160007 · Cited by 39
Retroviral Transfer and Long-Term Expression of the Adrenoleukodystrophy Gene in Human CD34 + Cells
Doerflinger, N., Micléa, J.-M., Lopez, J., Chomienne, C., Bougneres, P. F., Aubourg, P. R., & Cartier, N. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.7-1025 · Cited by 39
Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy
Baarine, M., Khan, M., Singh, A., & Singh, I. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143238 · Cited by 38
Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy
Musolino, P. L., Rapalino, O., Caruso, P., Caviness, V. S., & Eichler, F. S. (2012) · Brain · doi:10.1093/brain/aws206 · Cited by 37
Seven-Tesla proton magnetic resonance spectroscopic imaging in adult X-linked adrenoleukodystrophy
Ratai, E., Kok, T., Wiggins, C., Wiggins, G., Grant, E., Gagoski, B., O’Neill, G., Adalsteinsson, E., & Eichler, F. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1488 · Cited by 37
Adrenoleukodystrophy in Norway: High Rate of De Novo Mutations and Age-Dependent Penetrance
Horn, M. A., Retterstøl, L., Abdelnoor, M., Skjeldal, O. H., & Tallaksen, C. M. E. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.12.007 · Cited by 41
Structural basis of substrate recognition and translocation by human very long-chain fatty acid transporter ABCD1
Chen, Z.-P., Xu, D., Wang, L., Mao, Y.-X., Li, Y., Cheng, M.-T., Zhou, C.-Z., Hou, W.-T., & Chen, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-30974-5 · Cited by 37
Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency
Oezen, I., Rossmanith, W., Forss‐Petter, S., Kemp, S., Voigtländer, T., Moser-Thier, K., Wanders, R. J. A., Bittner, R. E., & Berger, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi125 · Cited by 37
Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency
Dumser, M., Bauer, J., Lassmann, H., Berger, J., & Forss‐Petter, S. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0288-4 · Cited by 36
[56] Peroxisomal ABC transporters
Shani, N., & Valle, D. L. (1998) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(98)92058-4 · Cited by 35
Imaging Manifestations of the Leukodystrophies, Inherited Disorders of White Matter
Yang, E., & Prabhu, S. P. (2014) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2013.11.008 · Cited by 35
Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics
Habekost, C. T., Schestatsky, P., Torres, V. F., de Coelho, D. M., Vargas, C. R., Torrez, V., Oses, J. P., Portela, L. V., Pereira, F. D. S., Matte, U., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-6 · Cited by 35
The importance of testing for adrenoleucodystrophy in males with idiopathic Addison's disease
Ronghe, M. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.3.185 · Cited by 35
Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics
Genin, E. C., Gondcaille, C., Trompier, D., & Savary, S. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.04.006 · Cited by 34
Dendrimer–N‐acetyl‐L‐cysteine modulates monophagocytic response in adrenoleukodystrophy
Turk, B. R., Nemeth, C. L., Marx, J. S., Tiffany, C. W., Jones, R. O., Theisen, B. E., Kambhampati, S. P., Ramireddy, R. R., Singh, S., Rosen, M. H., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25303 · Cited by 34
Lysosomal and Peroxisomal Disorders
Thomas, P. K., & Goebel, H. H. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50082-x · Cited by 34
Modulation of the peroxisomal gene expression pattern by dehydroepiandrosterone and vitamin D: therapeutic implications
Depreter, M., Vandesompele, J., Espeel, M., Speleman, F., & Roels, F. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750779 · Cited by 34
Brain disorders and psychopathology
Heyman, I., Skuse, D., & Goodman, R. (2015) · Wiley eBooks · doi:10.1002/9781118381953.ch31 · Cited by 35
The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis
Wang, X.-M., Yik, W. Y., Zhang, P., Lu, W., Dranchak, P. K., Shibata, D., Steinberg, S. J., & Hacia, J. G. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt130 · Cited by 33

Authors: Moser, H. W., Mahmood, A., & Raymond, G. V.
Affiliations: Kennedy Krieger Institute (US)
Corresponding author: Raymond, Gerald V
ORCID: Raymond, Gerald V
Venue: Nature Clinical Practice Neurology
Publisher: Springer Science and Business Media LLC
Published: 2007-03
Volume: 3
Issue: 3
Pages: 140-151
ISSN: 1745-834X (ISSN-L)
1745-8358
DOI: 10.1038/ncpneuro0421
OpenAlex: W2222090074
Cited by: 663
References: 99
Citations by year: 2026: 15 · 2025: 20 · 2024: 26 · 2023: 22 · 2022: 20 · 2021: 21 · 2020: 28 · 2019: 17 · 2018: 23 · 2017: 24 · 2016: 27 · 2015: 21 · 2014: 39 · 2013: 28 · 2012: 39
FWCI: 5.72
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Clinical Practice Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: Johns Hopkins University
National Institutes of Health
U.S. Public Health Service (M0-1-R00052)
National Center for Research Resources
NIH Clinical Center
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD039276, HD-10981, HD39276, P01HD010981)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords: X-linked adrenoleukodystrophy, ABCD1 gene, very long chain fatty acids, peroxisomal membrane proteins, ABC transporters, adrenomyeloneuropathy, Addison's disease, newborn screening, prenatal diagnosis, carrier identification, Lorenzo's oil, genetic counseling, misdiagnosis
MeSH terms: Adrenoleukodystrophy, Drug Combinations, Erucic Acids, Humans, Magnetic Resonance Imaging, Phenotype, Triolein, Hematopoietic Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

X-linked adrenoleukodystrophy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks